Is Bloom Energy Flying Under the Radar?
Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…
Sell
45
JAZZ Quote, Financials, Valuation and Earnings
Last price:
$112.91
Seasonality move
:
5.15%
Day range:
$112.16 - $115.34
52-week range:
$95.49 - $148.06
Dividend yield:
0%
P/E ratio:
15.05x
P/S ratio:
1.77x
P/B ratio:
1.64x
Volume:
564.1K
Avg. volume:
681.1K
1-year change:
3.7%
Market cap:
$6.8B
Revenue:
$4.1B
EPS (TTM):
$7.50
Earnings Data
Next earnings date for JAZZ
Jul 31
2025
Most recent earnings per share
-$1.52
Missed by $6.18
(May 6/2025)
Consensus Estimate
$4.66
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JAZZ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $1.1B | -- | -- | $5.02 | -- |
| 07/31/2025 | Q2 | $1B | -- | -- | -$6.26 | -- |
| 05/06/2025 | Q1 | $983.8M | $897.8M | -$1.52 | $4.66 | -$6.18 |
| 02/25/2025 | Q4 | $1.1B | $1.1B | $3.11 | $5.81 | -$2.70 |
| 11/06/2024 | Q3 | $1B | $1.1B | $3.42 | $5.50 | -$2.08 |
| 07/31/2024 | Q2 | $1B | $1B | $2.49 | $4.78 | -$2.29 |
| 05/01/2024 | Q1 | $954.3M | $902M | -$0.23 | $4.18 | -$4.41 |
| 02/28/2024 | Q4 | $1B | $1B | $1.42 | $5.18 | -$3.76 |
| 11/08/2023 | Q3 | -- | -- | $2.14 | $4.93 | -$2.79 |
| 08/09/2023 | Q2 | -- | -- | $1.52 | $4.43 | -$2.91 |
| 05/10/2023 | Q1 | -- | -- | $1.04 | $4.22 | -$3.18 |
| 03/01/2023 | Q4 | -- | -- | -$3.82 | $1.12 | -$4.94 |
| 11/09/2022 | Q3 | -- | -- | -$0.31 | $4.67 | -$4.98 |
| 08/03/2022 | Q2 | -- | -- | $0.55 | $4.19 | -$3.64 |
| 05/04/2022 | Q1 | -- | -- | $0.03 | $3.89 | -$3.86 |
| 03/01/2022 | Q4 | -- | -- | -$0.57 | $3.64 | -$4.21 |
| 11/09/2021 | Q3 | -- | -- | -$0.86 | $3.31 | -$4.17 |
| 08/03/2021 | Q2 | -- | -- | -$6.11 | $3.45 | -$9.56 |
| 05/04/2021 | Q1 | -- | -- | $2.09 | $3.73 | -$1.64 |
| 02/23/2021 | Q4 | -- | -- | $2.33 | $4.20 | -$1.87 |
| 11/02/2020 | Q3 | -- | -- | $2.64 | $4.08 | -$1.44 |
| 08/04/2020 | Q2 | -- | -- | $2.06 | $3.11 | -$1.05 |
| 05/05/2020 | Q1 | -- | -- | -$2.82 | $0.67 | -$3.49 |
| 02/25/2020 | Q4 | -- | -- | $1.29 | $4.12 | -$2.83 |
| 11/05/2019 | Q3 | -- | -- | $1.78 | $3.59 | -$1.81 |
| 08/06/2019 | Q2 | -- | -- | $4.05 | $3.57 | $0.48 |
| 05/07/2019 | Q1 | -- | -- | $3.67 | $3.16 | $0.51 |
| 02/26/2019 | Q4 | -- | -- | $3.64 | $3.03 | $0.61 |
| 11/06/2018 | Q3 | -- | -- | $3.58 | $3.32 | $0.26 |
| 08/07/2018 | Q2 | -- | -- | $3.49 | $3.21 | $0.28 |
| 05/08/2018 | Q1 | -- | -- | $2.98 | $2.78 | $0.20 |
| 02/27/2018 | Q4 | -- | -- | $2.95 | $2.96 | -$0.01 |
| 11/07/2017 | Q3 | -- | -- | $3.22 | $2.89 | $0.33 |
| 08/08/2017 | Q2 | -- | -- | $2.56 | $2.75 | -$0.19 |
| 05/09/2017 | Q1 | -- | -- | $2.31 | $2.34 | -$0.03 |
| 02/28/2017 | Q4 | -- | -- | $1.91 | $1.65 | $0.26 |
| 11/08/2016 | Q3 | -- | -- | $2.16 | $1.57 | $0.59 |
| 08/09/2016 | Q2 | -- | -- | $1.80 | $1.71 | $0.09 |
| 05/10/2016 | Q1 | -- | -- | $1.87 | $1.31 | $0.56 |
| 02/23/2016 | Q4 | -- | -- | $2.27 | $1.66 | $0.61 |
| 11/09/2015 | Q3 | -- | -- | $1.39 | $1.49 | -$0.10 |
Jazz Pharmaceuticals PLC Earnings Questions
-
How Much did Jazz Pharmaceuticals PLC Generate in Revenue Last Quarter?
Jazz Pharmaceuticals PLC reported $897.8M worth of top line sales in its most recent quarter.
-
Did Jazz Pharmaceuticals PLC Beat Earnings Last Quarter?
Jazz Pharmaceuticals PLC announced earnings per share of -$1.52 which represents a miss of analyst forecast a $4.66 per share.
-
Is Jazz Pharmaceuticals PLC Profitable?
Jazz Pharmaceuticals PLC reported $793.2M that represents $13.01 per share over the last quarter.
-
What is the Analyst Consensus for Jazz Pharmaceuticals PLC EPS Next Year?
Jazz Pharmaceuticals PLC's earnings are forecast to decrease from $8.65 per share to $20.21 per share next year representing a decrease of -44.69%.
-
When is Jazz Pharmaceuticals PLC's Earnings Date?
Jazz Pharmaceuticals PLC's next earnings date is July 31, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
61
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
55
TLN alert for Jul 19
Talen Energy [TLN] is up 24.44% over the past day.
Sell
48
CRSP alert for Jul 19
CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.
Buy
83
SOC alert for Jul 19
Sable Offshore [SOC] is up 11.86% over the past day.
